Graham (GHM) Q1 Orders Soar 120%

Graham (NYSE:GHM) reported mixed Q1 FY2026 results, with non-GAAP EPS of $0.45 exceeding estimates, yet GAAP revenue of $55.5 million missed expectations. Despite the revenue shortfall, profitability improved significantly, marked by a gross margin expansion to 26.5% and a 33% rise in adjusted EBITDA. Operational strength was evident in orders more than doubling to $125.9 million, driving a record $482.9 million backlog, 87% of which is tied to Defense contracts. This robust backlog provides future revenue visibility, though investors should monitor the high defense concentration and the 35-40% near-term conversion rate.

Analysis

Graham Corporation (GHM) reported a bifurcated Q1 FY2026, characterized by robust profitability and order growth that overshadowed a notable top-line miss. The company's non-GAAP EPS of $0.45 significantly surpassed the $0.37 analyst estimate, driven by an expansion in gross margin to 26.5% and a 33% year-over-year increase in adjusted EBITDA to $6.8 million. This margin strength was supported by a 33% rise in high-margin aftermarket sales. However, GAAP revenue of $55.5 million fell approximately $8 million short of the $63.4 million expectation, despite an 11% year-over-year increase. The primary forward-looking indicator is the exceptional order intake of $125.9 million, which drove the book-to-bill ratio to 2.3x and created a record backlog of $482.9 million. This backlog, while providing significant revenue visibility, introduces considerable risk due to its high concentration, with 87% tied to Defense sector contracts. Management's guidance that only 35-40% of this backlog will convert to revenue in the next twelve months highlights the long-cycle nature of its projects and contextualizes the current revenue miss. Despite this, the company maintained its full-year FY2026 guidance for revenue and EBITDA, signaling confidence in its operational execution and ability to absorb up to $5 million in tariff costs.

Key Decisions for Investors

• Investors should view the record $482.9 million backlog and 2.3x book-to-bill ratio as strong positive signals, but must monitor the backlog-to-revenue conversion rate quarterly to validate the maintained full-year guidance.
• The heavy 87% concentration of the backlog in Defense contracts makes the stock highly sensitive to U.S. military budget cycles and program timelines, warranting close attention to developments in key naval and torpedo projects.
• Focus on the sustainability of the expanded 26.5% gross margin, as the ability to maintain profitability while ramping up production to work through the large order book is critical to the investment thesis.
• While near-term performance is tied to defense, long-term investors should assess the progress of strategic initiatives like the new cryogenic test facility and SCAMP pump applications, which offer potential for future revenue diversification and market expansion.